<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; cancer</title>
	<atom:link href="http://q-pharm.com/category/cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 03 Feb 2012 10:47:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>In-vitro study of DLX5 Ligands</title>
		<link>http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/</link>
		<comments>http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 14:44:09 +0000</pubDate>
		<dc:creator>Gulnara Yamanbaeva</dc:creator>
				<category><![CDATA[cancer]]></category>
		<category><![CDATA[Akt2-transgenic mice]]></category>
		<category><![CDATA[anti-tumor agents]]></category>
		<category><![CDATA[DLX5 ligands]]></category>
		<category><![CDATA[line 42 of T-cell lymphoma]]></category>
		<category><![CDATA[line 72 of T-cell lymphoma]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=563</guid>
		<description><![CDATA[The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team.
The reference:
R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...]


Related posts:<ol><li><a href='http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/' rel='bookmark' title='High Throughput Screening of Transcription factor DLX5'>High Throughput Screening of Transcription factor DLX5</a></li>
<li><a href='http://q-pharm.com/2009/11/experimental-sirna-complex-uptake-without-transfection-reagents/' rel='bookmark' title='Experimental siRNA complex uptake without transfection reagents'>Experimental siRNA complex uptake without transfection reagents</a></li>
<li><a href='http://q-pharm.com/2008/06/docking-validation-study-pdk1-kinase-oncology/' rel='bookmark' title='Docking validation study: PDK1-kinase (oncology)'>Docking validation study: PDK1-kinase (oncology)</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>High Throughput Screening of Transcription factor DLX5</title>
		<link>http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/</link>
		<comments>http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 14:23:10 +0000</pubDate>
		<dc:creator>Gulnara Yamanbaeva</dc:creator>
				<category><![CDATA[cancer]]></category>
		<category><![CDATA[3D model of a target protein]]></category>
		<category><![CDATA[compound library]]></category>
		<category><![CDATA[high throughput screening]]></category>
		<category><![CDATA[molecular docking]]></category>
		<category><![CDATA[protooncogene c-myc]]></category>
		<category><![CDATA[transcription factor DLX5]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=740</guid>
		<description><![CDATA[The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team
The reference:
R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...]


Related posts:<ol><li><a href='http://q-pharm.com/2012/01/in-vitro-study-of-dlx5-ligands/' rel='bookmark' title='In-vitro study of DLX5 Ligands'>In-vitro study of DLX5 Ligands</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/virtual-high-throughput-screening/' rel='bookmark' title='Virtual High Throughput Screening'>Virtual High Throughput Screening</a></li>
<li><a href='http://q-pharm.com/2010/08/application-of-a-novel-in-silico-high-throughput-screen-to-identify-selective-inhibitors-for-protein%e2%80%93protein-interactions/' rel='bookmark' title='Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions'>Application of a novel in silico high throughput screen to identify selective inhibitors for protein–protein interactions</a></li>
<li><a href='http://q-pharm.com/2009/11/experimental-sirna-complex-uptake-without-transfection-reagents/' rel='bookmark' title='Experimental siRNA complex uptake without transfection reagents'>Experimental siRNA complex uptake without transfection reagents</a></li>
<li><a href='http://q-pharm.com/2008/05/protein-flexibility-and-false-positives-detection/' rel='bookmark' title='Protein Flexibility and False Positives detection.'>Protein Flexibility and False Positives detection.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Experimental siRNA complex uptake without transfection reagents</title>
		<link>http://q-pharm.com/2009/11/experimental-sirna-complex-uptake-without-transfection-reagents/</link>
		<comments>http://q-pharm.com/2009/11/experimental-sirna-complex-uptake-without-transfection-reagents/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 14:19:35 +0000</pubDate>
		<dc:creator>timakhov</dc:creator>
				<category><![CDATA[cancer]]></category>
		<category><![CDATA[drug design]]></category>
		<category><![CDATA[oncology]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=125</guid>
		<description><![CDATA[Normally siRNA do not penetrate cell membranes without transfection reagents. In Quantum Pharmaceutical we developed a new nanoscale complex with ability to transport siRNA over cell membranes of a cancer [...]


Related posts:<ol><li><a href='http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/' rel='bookmark' title='From Biological Spectra (multiple protein binding data) to pharmacological profiling!'>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</a></li>
<li><a href='http://q-pharm.com/2012/01/high-throughput-screening-of-transcription-factor-dlx5/' rel='bookmark' title='High Throughput Screening of Transcription factor DLX5'>High Throughput Screening of Transcription factor DLX5</a></li>
<li><a href='http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/' rel='bookmark' title='Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.'>Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2009/11/experimental-sirna-complex-uptake-without-transfection-reagents/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Quantum enters collaboration with Children&#8217;s Cancer Institute Australia</title>
		<link>http://q-pharm.com/2008/10/quantum-pharmaceuticals-enters-collaboration-with-childrens-cancer-institute-australia/</link>
		<comments>http://q-pharm.com/2008/10/quantum-pharmaceuticals-enters-collaboration-with-childrens-cancer-institute-australia/#comments</comments>
		<pubDate>Tue, 28 Oct 2008 14:46:00 +0000</pubDate>
		<dc:creator>businessdev</dc:creator>
				<category><![CDATA[cancer]]></category>
		<category><![CDATA[collaboration]]></category>
		<category><![CDATA[oncology]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=43</guid>
		<description><![CDATA[
Moscow, October, 28 2008
Quantum announce drug discovery collaboration with Children&#8217;s Cancer Institute Australia&#8217;s (CCIA). Under the terms of the agreement Quantum gets access to CCIA in-house disease target data. Quantum [...]


Related posts:<ol><li><a href='http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/' rel='bookmark' title='Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.'>Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2008/03/quantum-pharmaceuticals-and-otechestvennye-lekarstva-ojsc-entered-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.'>Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2007/08/quantum-pharmaceuticals-and-molecmo-nanobiotechnologies-announce-collaboration/' rel='bookmark' title='Quantum and MOLECMO Nanobiotechnologies announce collaboration.'>Quantum and MOLECMO Nanobiotechnologies announce collaboration.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/10/quantum-pharmaceuticals-enters-collaboration-with-childrens-cancer-institute-australia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.</title>
		<link>http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/</link>
		<comments>http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/#comments</comments>
		<pubDate>Fri, 12 Sep 2008 14:45:35 +0000</pubDate>
		<dc:creator>timakhov</dc:creator>
				<category><![CDATA[cancer]]></category>
		<category><![CDATA[collaboration]]></category>
		<category><![CDATA[oncology]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=129</guid>
		<description><![CDATA[Quantum announce drug discovery collaboration with Fox Chase Cancer Center Under the terms of agreement Quantum will apply its state-of-the-art in-house drug discovery technology to discover novel small molecule inhibitors [...]


Related posts:<ol><li><a href='http://q-pharm.com/2008/10/quantum-pharmaceuticals-enters-collaboration-with-childrens-cancer-institute-australia/' rel='bookmark' title='Quantum enters collaboration with Children&#8217;s Cancer Institute Australia'>Quantum enters collaboration with Children&#8217;s Cancer Institute Australia</a></li>
<li><a href='http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/' rel='bookmark' title='Quantum collaborates with University of Pittsburgh on HIV drug discovery.'>Quantum collaborates with University of Pittsburgh on HIV drug discovery.</a></li>
<li><a href='http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/' rel='bookmark' title='Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.'>Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2008/03/quantum-pharmaceuticals-and-otechestvennye-lekarstva-ojsc-entered-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.'>Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

